U.S., Dec. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07306611) titled 'REGENERATIVE TREATMENT OF FEMALE GENITAL ATROPHY' on Dec. 14.
Brief Summary: Vulvovaginal health is a key aspect of active and healthy aging for all women. Hormonal deprivation that occurs during menopause significantly affects the anatomy and function of urogenital tissues, leading to their atrophy. Vaginal creams and suppositories containing estrogens are the standard treatment and can improve this condition. However, they require continuous application, which often makes adherence to treatment challenging. Additionally, women with hormone-dependent tumors, such as most breast cancers and many gynecological cancers, are even more ...